Constitutive over-expression of BCL2 in all hematopoietic lineages, in transgenic mice where the human BCL2 gene is fused to the Vav gene promoter, has a potent effect on the survival, development and maturation of many blood cell types [35] and results in increased incidence of follicular lymphoma [36]. This evidence concerns the gene BCL2 and follicular lymphoma.